Physician

Jerry Sebag, M.D., FACS, FRCOPHTH

According to 2025 Medicare claims, Jerry Sebag, M.D., FACS, FRCOPHTH (NPI: 1689601635) practices ophthalmology in the Anaheim-Santa Ana-Irvine, CA market, with the plurality of this provider's patient population coming from Orange, CA. This provider's primary affiliated billing organization is VMR INSTITUTE, A MEDICAL CORPORATION (NPI: 1609945146; TIN: 204532718) and primary practice location at 92647-3098.

Sebag's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 439 traditional Medicare patients, billed 53,489 HCPCS/CPT codes, and received $2,405,765 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 36 prescription claims across 19 beneficiaries totaling $33,958 in drug costs. Open Payments data shows 3 records totaling $1,732. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $3,778,416 to $2,405,765. In contrast, Part D prescription costs have risen steadily, from $20,039 to $33,958. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.8M2015 Medicare payment: $3,778,416 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,085,928 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,699,248 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,062,777 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,831,033 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,337,627 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,643,690 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,896,244 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,903,872 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,405,765 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201572519,413$3,778,416
201667216,962$3,085,928
201767115,462$2,699,248
201861011,680$2,062,777
20195318,524$1,831,033
20203964,341$1,337,627
20213875,296$1,643,690
20224045,963$1,896,244
202342917,589$1,903,872
202443953,489$2,405,765

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$21K$43K2015 Drug cost: $20,039 (USD; Tot_Drug_Cst)2016 Drug cost: $12,795 (USD; Tot_Drug_Cst)2017 Drug cost: $21,610 (USD; Tot_Drug_Cst)2018 Drug cost: $23,955 (USD; Tot_Drug_Cst)2019 Drug cost: $27,152 (USD; Tot_Drug_Cst)2020 Drug cost: $22,150 (USD; Tot_Drug_Cst)2021 Drug cost: $42,953 (USD; Tot_Drug_Cst)2022 Drug cost: $38,797 (USD; Tot_Drug_Cst)2023 Drug cost: $28,575 (USD; Tot_Drug_Cst)2024 Drug cost: $33,958 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201580171$20,039
201658103$12,795
201773151$21,610
201854130$23,955
201962177$27,152
20201961$22,150
20212482$42,953
20221848$38,797
20231535$28,575
20241936$33,958

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye364743$152
92012Established patient problem focused exam of visual system3671,205$77
92082Exam of visual field with intermediate testing237402$43
92134Imaging of retina302750$35
92250Photography of the retina382780$31

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$1,732F. Hoffmann-La Roche AG
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jerry Sebag, M.D., FACS, FRCOPHTH?

Tedicare shows public-source Medicare data for Jerry Sebag, M.D., FACS, FRCOPHTH (NPI 1689601635), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jerry Sebag, M.D., FACS, FRCOPHTH have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jerry Sebag, M.D., FACS, FRCOPHTH?

Jerry Sebag, M.D., FACS, FRCOPHTH is linked to VMR INSTITUTE, A MEDICAL CORPORATION (billing NPI 1609945146) in the available physician profile data.

Does Jerry Sebag, M.D., FACS, FRCOPHTH have Open Payments data?

Jerry Sebag, M.D., FACS, FRCOPHTH has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.